Arvinas (ARVN) Assets Average (2018 - 2026)

Arvinas' (ARVN) quarterly Assets Average came in at $682.7 million in Q1 2026, down 34.75% year-on-year from $1.0 billion in Q1 2025, and down 12.6% quarter-over-quarter from $781.1 million in Q4 2025.

Arvinas (ARVN) Assets Average (2018 - 2026) Analysis & Trends

Arvinas' Assets Average history runs 9 years deep, the most recent figure standing at $682.7 million for Q1 2026.

  • On a quarterly basis, Assets Average fell 34.75% year-over-year to $682.7 million in Q1 2026; TTM through Mar 2026 was $682.7 million, a 34.75% decrease from a year earlier, with the FY2025 full-year figure at $904.6 million, down 24.49% from the prior year.
  • Assets Average retreated to $682.7 million in Q1 2026 per ARVN's latest filing, from $781.1 million in the prior quarter.
  • Across five years, Assets Average topped out at $1.5 billion in Q1 2022 and bottomed at $682.7 million in Q1 2026.
  • The 5-year median for Assets Average is $1.2 billion (2023), against an average of $1.1 billion.
  • Across the five-year window, Assets Average jumped 119.41% in 2022 and slumped 34.75% in 2026, its largest moves.
  • Year by year, Assets Average stood at $1.3 billion in 2022, then fell by 9.24% to $1.2 billion in 2023, then slipped by 4.42% to $1.1 billion in 2024, then tumbled by 30.83% to $781.1 million in 2025, then slipped by 12.6% to $682.7 million in 2026.
  • Per Business Quant, the three latest ARVN Assets Average figures stand at $682.7 million (Q1 2026), $781.1 million (Q4 2025), and $876.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 303.40 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 65.01 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.37 Bn
4 NuCana 279.75 Bn 279.75 Bn - 41.64 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.06 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.71 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.91 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.30 Bn
10 Arvinas 519.68 Mn -95.22 Mn - 682.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 682.70 Mn
Dec 31, 2025 781.10 Mn
Sep 30, 2025 876.80 Mn
Jun 30, 2025 955.20 Mn
Mar 31, 2025 1.05 Bn
Dec 31, 2024 1.13 Bn
Sep 30, 2024 1.22 Bn
Jun 30, 2024 1.25 Bn
Mar 31, 2024 1.26 Bn
Dec 31, 2023 1.18 Bn
Sep 30, 2023 1.07 Bn
Jun 30, 2023 1.13 Bn
Mar 31, 2023 1.22 Bn
Dec 31, 2022 1.30 Bn
Sep 30, 2022 1.37 Bn
Jun 30, 2022 1.45 Bn
Mar 31, 2022 1.53 Bn
Dec 31, 2021 1.59 Bn
Sep 30, 2021 1.12 Bn
Jun 30, 2021 662.90 Mn